Most adolescents with ADHD have indifferent attitudes toward medication

Results showed that 83% of study participants had an indifferent attitude toward their ADHD medication, and 61% reported to be nonadherent. Most adolescents taking medication for attention-deficit/hyperactivity disorder (ADHD) report that they are indifferent toward their medication and frequently skip doses, according to data published in the Journal of Adolescent Health.

Read More

Structural Differences in the ADHD Brain

Scientists have been able to map out areas of the brain that are affected by childhood ADHD and adult ADHD, and have noticed that the brain morphology changes as an individual also ages. This study, published in the Public Library of Science, is the first to bridge the gap between childhood and adulthood ADHD by…

Read More

Is it Really ADHD or is it Trauma?

While ADHD is a very real executive functioning brain issue that affects 7.2% of adolescents globally (according to CHADD)—there is major problem with this situation. All too often, nobody takes into account the other likely diagnosis: Trauma.

Read More

Women with undiagnosed ADHD at risk of suicide, says US psychologist

Girls and women with undiagnosed Attention Deficit Hyperactivity Disorder (ADHD) are at risk of anxiety, depression and suicide, a leading American clinical psychologist has said. Dr Ellen B Littman said because of societal expectations, girls with the condition tend to try to conform in class, so are less likely to demonstrate the hyperactivity seen in…

Read More

Children with ADHD likely to have touch-processing abnormalities

A new study finds that children with ADHD fare worse on several tests of tactile functioning, including reaction time and detecting a weak stimulus on the skin (detection threshold). The article, published ahead of print in the Journal of Neurophysiology, was chosen as an APSselect article for October.

Read More

Collaborative Care For Pediatric Behavior Disorders is Cost Effective and Improves Clinical Outcomes

A random control study determined that doctor-office collaborative care (DOCC) focused on pediatric behavior healthcare services in primary pediatric care settings, not only improves clinical effectiveness of treatment for pediatric patients, but is cost effective during both the initial intervention and post-intervention follow-up periods when compared to patients receiving enhanced usual care (EUC).

Read More

What New Drugs Are in the Pipeline to Treat ADHD?

Strattera. Adderall. Concerta. Ritalin. They’re all commonly-prescribed medications for treating attention deficit hyperactivity disorder symptoms, and all are still on the market. But some new ones recently became available to the public, while yet another ADHD medication is currently seeking FDA approval.

Read More